HIV decision support: From molecule to man

Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences

Volumn 367, Issue 1898, 2009, Pages 2691-2703

  Sloot, P M A ^a   Coveney, Peter V ^b   Ertaylan, G ^a   Muller V ^c   Boucher, C A ^d   Bubak, M ^a,e  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

Author keywords

Decision support; Drug resistance; Human immunodeficiency virus; Multilevel modelling; Systems biology

Indexed keywords

BIOLOGY;

DECISION SUPPORT; DRUG RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS; MULTILEVEL MODELLING; SYSTEMS BIOLOGY;

DECISION SUPPORT SYSTEMS;

COMPUTER PROGRAM; DISEASE COURSE; EUROPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE PROGRESSION; EUROPE; HIV INFECTIONS; HUMANS; MALE; SOFTWARE;

EID: 67650421988     PISSN: 1364503X     EISSN: None     Source Type: Journal    
DOI: 10.1098/rsta.2009.0043     Document Type: Article

References (26)

1. Bubak, M. et al. 2008 Virtual laboratory for development and execution of biomedical collaborative applications. In Proc. 21st IEEE Int. Symp. on Computer-Based Medical Systems (CBMS 2008), Jyväskylä, Finland, 17-19 June 2008, pp. 373-378. Washington, DC: IEEE Computer Society.
2. Coveney, P. V., Saksena, R. S., Zasada, S. J., McKeown, M. & Pickles, S. 2007 The application hosting environment: lightweight middleware for grid-based computational science. Comput. Phys. Commun. 176, 406-418. (doi:10.1016/j.cpc.2006.11.011) (Pubitemid 46298984)
3. Deforche, K. et al. 2007 Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors. Infect. Genet. Evol. 7, 382-390. (doi:10.1016/j.meegid.2006.09.004) (Pubitemid 46667768)
4. Deforche, K. et al. 2008 Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment. Bioinformatics (Oxf., Engl.) 24, 34-41. (doi:10.1093/bioinformatics/btm540)
5. Delgado, J., Heath, K., Yip, B., Marion, S., Alfonso, V., Montaner, J., O'Shaughnessy, M. V. & Hogg, R. S. 2003 Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refill. Antiviral Ther. 8, 471-478. (Pubitemid 37351566)
6. Department of Health and Human Services 2008 AIDSinfo. Retrieved 8 April 2008, from Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. See &z.ast;http://www.aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL.pdf.
7. Ermolieff, J., Lin, X. & Tang, J. 1997 Kinetic properties of saquinavir-resistant mutants of human immunodeficiency virus type 1 protease and their implications in drug resistance in vivo. Biochemistry 36, 12 364-12 370. (doi:10.1021/bi971072e) (Pubitemid 27440977)
8. Ertaylan, G. & Sloot, P. 2008 A complex automata model of HIV-1 co-receptor tropism. In Proc. 3rd Int. Workshop in Targeting HIV Entry, Washington, DC, vol.2 (eds C. Boucher & J. Schapiro). Reviews in antiretroviral therapy, p. 25. Utrecht, The Netherlands: Virology Education.
9. Fang, C. T. et al. 2007 Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy. QJM Mon. J. Assoc. Phys. 100, 97-105. (doi:10.1093/ qjmed/hcl141) (Pubitemid 46332120)
10. Gubala, T. et al. 2007 ViroLab virtual laboratory. In Cracow Grid Workshop 2007 Workshop Proc., Cracow, Poland, pp. 35-40.
11. Haub, C. 2007 World population highlights: key findings from PRB's 2007 world population data sheet. Population bulletin. Washington, DC: Population Reference Bureau.
12. Hoffman, N. G., Schiffer, C. A. & Swanstrom, R. 2003 Covariation of amino acid positions in HIV-1 protease. Virology 314, 536-548. (doi:10.1016/S0042-6822(03)00484-7) (Pubitemid 37206360)
13. Huang, K. & Wooley, D. 2005 A new cell-based assay for measuring the forward mutation rate of HIV-1. J. Virol. Methods 124, 95-104. (doi:10.1016/j.jviromet.2004.11.010) (Pubitemid 40138784)
14. Kitahata, M., Van Rompaey, S. & Shields, A. 2000 Physician experience in the care of HIVinfected persons is associated with earlier adoption of new antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 24, 106-114. (Pubitemid 30640955)
15. Mansky, L. & Temin, H. 1995 Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69, 5087-5094.
16. Maschera, B., Darby, G., Palú, G., Wright, L., Tisdale, M., Myers, R., Blair, E. D. & Furfine, E. S. 1996 Human immunodeficiency virus. Mutations in the viral protease that confer resistance to saquinavir increase the dissociation rate constant of the protease-saquinavir complex. J. Biol. Chem. 271, 33 231-33 235. (doi:10.1074/jbc.271.52.33231) (Pubitemid 27010130)
17. Mathers, C. & Loncar, D. 2006 Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3, e442. (doi:10.1371/journal. pmed.0030442)
18. Sadiq, S., Wan, S. & Coveney, P. V. 2007 Insights into a mutation-assisted lateral drug escape mechanism from the HIV-1 protease active site. Biochemistry 46, 14 865-14 877. (doi:10.1021/ bi700864p) (Pubitemid 350308878)
19. Sadiq, S., Wright, D., Watson, S., Zesada, S., Stoica, S. & Coveney, P. V. 2008 Automated molecular simulation based binding affinity calculator for ligand-bound HIV-1 proteases. J. Chem. Inf. Model. 48, 1909-1919. (doi:10.1021/ci8000937)
20. Sanjuán, R., Moya, A. & Elena, S. 2004 The distribution of fitness effects caused by singlenucleotide substitutions in an RNA virus. Proc. Natl Acad. Sci. USA 101, 8396-8401. (doi:10. 1073/pnas.0400146101) (Pubitemid 38736586)
21. Sloot, P. M. A., Chen, F. & Boucher, C. 2002 Cellular automata model of drug therapy for HIV infection. In 5th Int. Conf. on Cellular Automata for Research and Industry, Geneva, Switzerland, vol.2493 (eds S. Bandini & B. T. Chopard), pp. 282-293. Lecture Notes in Computer Science.
22. Sloot, P. M. A., Tirado-Ramos, A., Altintas, I., Bubak, M. T. & Boucher, C. A. 2006 From molecule to man: decision support in individualized e-health. IEEE Comput. 39(11), 40-46.
23. Sloot, P. M. A., Ivanov, S., Boukhanovsky, A., van de Vijver, D. & Boucher, C. 2008a Stochastic simulation of HIV population dynamics through complex network modeling. Int. J. Comput. Math. 85, 1175-1187. (doi:10.1080/00207160701750583)
24. Sloot, P. M. A., Coveney, P. V., Bubak, M. T., Vandamme, A.-M., Nualláin, B.O ́., van de Vijver, D.& Boucher, C. A. B. 2008b ViroLab: a collaborative decision support system in viral disease treatment. Rev. Antiviral Ther. 3, 4-7.
25. Stoica, I., Sadiq, S. K. & Coveney, P. V. 2008 Rapid and accurate prediction of binding free energies for saquinavir-bound HIV-1 proteases. J. Am. Chem. Soc. 130, 2639-2648. (doi:10. 1021/ja0779250) (Pubitemid 351304779)
26. UNAIDS 2008 Report on the global AIDS epidemic. Geneva, Switzerland: UNAIDS.